Get started
Author

Elisabet Hjerpe

Observed name: E. Hjerpe
ORCID: 0000-0001-9456-5392
Observed ORCID: 0000-0001-9456-5392
OpenAlex ID: A5014999968
Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
2019 · Karin Stålberg, Maria Bjurberg, et al. · Acta Oncologica · 102
PDF
Genome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathy
2013 · Luis J Leandro-García, Lucía Inglada-Pérez, et al. · Journal of Medical Genetics · 79
Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites
2012 · My Wintzell, Elisabet Hjerpe, et al. · BMC Cancer · 68
PDF
Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study
2017 · Per Rosenberg, Preben Kjølhede, et al. · Acta Oncologica · 67
PDF
Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer
2020 · Lidia Moyano‐Galceran, Elina A Pietilä, et al. · EMBO Molecular Medicine · 66
PDF
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)
2017 · Kristina Lindemann, Emma Gibbs, et al. · British Journal of Cancer · 54
PDF
HSP60 Predicts Survival in Advanced Serous Ovarian Cancer
2013 · Elisabet Hjerpe, Suzanne Egyhazi, et al. · International Journal of Gynecological Cancer · 54
Metabolic markers GAPDH, PKM2, ATP5B and BEC-index in advanced serous ovarian cancer
2013 · Elisabet Hjerpe, Suzanne Egyhazi Brage, et al. · BMC Clinical Pathology · 48
PDF
Ovarian carcinoma cells with low levels of β-F1-ATPase are sensitive to combined platinum and 2-deoxy- d -glucose treatment
2009 · Emma Hernlund, Elisabet Hjerpe, et al. · Molecular Cancer Therapeutics · 41
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study
2017 · Elisabet Hjerpe, Christian Staf, et al. · Acta Oncologica · 28
PDF
Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study
2019 · Maria Bjurberg, Erik Holmberg, et al. · Gynecologic Oncology · 24
Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG study
2020 · Kristina Hellman, Erik Holmberg, et al. · Gynecologic Oncology · 22
Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds
2020 · Sylvain Peuget, Jiawei Zhu, et al. · Cancer Research · 18
PDF
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study
2021 · Christer Borgfeldt, Erik Holmberg, et al. · BMC Cancer · 12
PDF
Implementation of National Guidelines increased survival in advanced ovarian cancer - A population-based nationwide SweGCG study
2021 · Pernilla Dahm-Kähler, Erik Holmberg, et al. · Gynecologic Oncology · 12
Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging
2017 · Sahar Salehi, Robert Mohammar, et al. · Acta Oncologica · 12
PDF
Metabolic Markers and HSP60 in Chemonaive Serous Solid Ovarian Cancer Versus Ascites
2014 · Elisabet Hjerpe, Suzanne Egyhazi Brage, et al. · International Journal of Gynecological Cancer · 6
Precision Oncology of High-Grade Ovarian Cancer Defined through Targeted Sequencing
2021 · Sandra Wessman, Beatriz Fuentes, et al. · Cancers · 4
PDF
[Ovarian cancer is in many ways a heterogeneous disease].
2015 · Susanne Malander, Elisabet Hjerpe, et al. · PubMed · 2
Molecular steps towards improving prognosis in ovarian cancer
2014 · Elisabet Hjerpe · Figshare · 1
Is endometroid cancer of the ovaries a late manifestation of Alström syndrome?
2009 · E. Moberg, E. Hjerpe, et al. · Journal of Internal Medicine · 1
PDF
Data from Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds
2023 · Sylvain Peuget, Jiawei Zhu, et al.
Supplementary Materials and Methods from Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds
2023 · Sylvain Peuget, Jiawei Zhu, et al.
PDF
Supplementary Figures and Legends from Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds
2023 · Sylvain Peuget, Jiawei Zhu, et al.
Table S3 from Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds
2023 · Sylvain Peuget, Jiawei Zhu, et al.
Works count: 38
Citation count: 721
H-index: 13
I10-index: 16
Year
Topic
Type